Education
About Us
Working with TipRanks
Follow Us
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
Alto-100
Bipolar Disorder I Or Ii With A Major Depressive Episode
Phase II
Recruiting
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Oct 15, 2024
―
Alto-101, Alto-101 Transdermal Delivery System
Schizophrenia, Cognitive Impairment
Phase II
Recruiting
Study of ALTO-101 in Patients With Schizophrenia
Jul 09, 2024
―
Alto-203 25 Μg, Alto-203 75 Μg
Major Depressive Disorder, Anhedonia
Phase II
Completed
PD, PK, and Safety of ALTO-203 in Patients With MDD
Apr 08, 2024
―
Alto-300
Major Depressive Disorder
Phase II
Recruiting
Study of ALTO-300 in MDD
May 26, 2023
―
Alto-100
Major Depressive Disorder
Phase II
Completed
Phase 2b Study of ALTO-100 in MDD
Dec 24, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alto Neuroscience, Inc. (ANRO) have in its pipeline
ANRO is currently developing the following drugs: Alto-100, Alto-101, Alto-101 Transdermal Delivery System, Alto-203 25 Μg, Alto-203 75 Μg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.